1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 06 JULY 2015

Cancer Drug News 06 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Bespoke Medicine Success Reliant On Manufacturing Efficiences
Industry Trend Analysis - Cost Will Impact Perjeta's Success In Europe
Industry Brief - Takeda's Adcetris First Ultra-Orphan Medicine Recommended By AWMSG
Industry Brief - CHMP Adopts Positive Opinion On Novartis' Farydak For MM
Industry Brief - Opdivo Becomes First LC Treatment Approved Under UK EAMS
Industry Trend Analysis - Lilly Alimta Appeal Win To Push Back Generic Competition
Industry Trend Analysis - Clovis Still Faces AstraZeneca Threat After Filing First
Industry Trend Analysis - Increased Targeting Will Lead To Super Niche Cancer Markets
Industry Brief - Telesta Submits BLA For MCNA To FDA
Industry Brief - Immunovaccine/Incyte Collaborate On Immunotherapy Combination
Industry Brief - PharmaMar Initiates Phase III Study Of PM1183 In Platinum-Resistant OC
Industry Brief - AEterna Zentaris Completes Enrolment In Zoptarelin Doxorubicin Phase III Trial
Industry Brief - MM-398 Receives FDA Priority Review Designation; Acceptance Of EU MAA
Industry Trend Analysis - Array's BRAF Inhibitor Success Relies On Differentiation
Industry Brief - Immunocore/Lilly Enter Immunotherapy Combination Trial Collaboration In Melanoma
Industry Trend Analysis - Cobimetinib/Zelboraf Combination Will Gain Delayed FDA Approval
Industry Brief - Eisai Launches Lenvima In Nordic Region For RAI-Refractory DTC
Industry Trend Analysis - Continuous Manufacturing Represents Future Of Pharmaceutical Production
Industry Brief - Peregrine Granted Key European Patent For Bavituximab
Industry Trend Analysis - Cancer Drug Pricing To Remain In Firing Line
Industry Brief - ViraTherapeutics Raises Funds To Advance Novel Oncolytic Virus Platform
Industry Brief - Provectus/Boehringer Collaborate To Bring PV-10 Into China
Industry Brief - Zosyn Receives Japanese Approval For Febrile Neutropenia
Industry Brief - Phase III Study Of Single-Dose Emend For Injection Regimen Meets Primary Endpoint
Industry Trend Analysis - Increased CAR-T Investment View Playing Out
Industry Brief - Panther To Acquire Alchemia Oncology
Industry Brief - Baxalta Launched To Deliver Therapies For Orphan Diseases And Underserved Conditions
Industry Brief - Medigene Raises Funds To Accelerate Cancer Immunotherapy Programmes

Table Of Contents

Cancer Drug News 06 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.